Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Kollmannsberger C, Tandstad T, Bedard PL, Cohn-Cedermark G, Chung PW, Jewett MA, et al. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol. 2014. https://doi.org/10.1200/jco.2014.56.2116.
2. Tarin TV, Sonn G, Shinghal R. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol. 2009;181:627–32. discussion 632–623.
3. Huang MM, Su ZT, Cheaib JG, Biles MJ, Allaf ME, Patel HD, et al. Cost-effectiveness analysis of non-risk-adapted active surveillance for postorchiectomy management of clinical stage I seminoma. Eur Urol Focus. 2020. https://doi.org/10.1016/j.euf.2020.06.012.
4. Almstrup K, Lobo J, Mørup N, Belge G, Rajpert-De Meyts E, Looijenga LH, et al. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours. Nat Rev Urol. 2020;17:201–13.
5. Rothermundt C, Thurneysen C, Cathomas R, Müller B, Mingrone W, Hirschi-Blickenstorfer A, et al. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). Swiss Med Wkly. 2018;148:w14640.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献